Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion type Assertion NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_head.
- NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion description "[Although case-control studies suggest that African Americans with common coding variants in the APOL1 gene are 5-29 times more likely than those individuals without such variants to have focal segmental glomerulosclerosis, HIV-associated nephropathy, or ESRD, prospective studies have not yet evaluated the impact of these variants on CKD in a community-based sample of African Americans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_provenance.
- NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion evidence source_evidence_literature NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_provenance.
- NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion SIO_000772 23766536 NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_provenance.
- NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion wasDerivedFrom befree-20150227 NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_provenance.
- NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_assertion wasGeneratedBy ECO_0000203 NP797830.RAxv9aiO97rlVXUCB0HptUE-HvSZnm-4CVp8E8eug49pA130_provenance.